VS-5584 25mg 25mg | Purity Not Available
Adooq Bioscience
VS-5584 is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
More Information Supplier PageVS-5584 is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
More Information Supplier PageVS-5584 is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
More Information Supplier PageVS-5584 is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
More Information Supplier PageSiramesine Hydrochloride is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of cancer cells and to exhibit a potent anticancer activity in vivo.
More Information Supplier PageSiramesine Hydrochloride is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of cancer cells and to exhibit a potent anticancer activity in vivo.
More Information Supplier PageSiramesine Hydrochloride is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of cancer cells and to exhibit a potent anticancer activity in vivo.
More Information Supplier PageBAY 11-7085 is an irreversible inhibitor of TNF??-induced I??B?? phosphorylation with IC50 of 10 ??M.
More Information Supplier PageBAY 11-7085 is an irreversible inhibitor of TNF??-induced I??B?? phosphorylation with IC50 of 10 ??M.
More Information Supplier PageBAY 11-7085 is an irreversible inhibitor of TNF??-induced I??B?? phosphorylation with IC50 of 10 ??M.
More Information Supplier Page